|
|
 |
|
Viewing report
|
|
|
|
Anti-Counterfeiting Strategies - Combating Fake Pharmaceuticals
Datamonitor, Dec 2007, Pages: 115
Accenture Ltd
Alliance Imaging Inc
Analytical Surveys Inc.
AstraZeneca PLC
Cardinal Health, Inc.
Eli Lilly and Company
GlaxoSmithKline Plc
Hewlett-Packard Company
Independent News & Media PLC
Integrated Communications Networks, Inc.
Johnson & Johnson
LDC
Medicines Company, The
Merck & Co., Inc.
Merck KGaA
Pfizer Inc
Purdue Pharma
Reuters Group Plc
Safety Insurance Group, Inc.
US Oncology, Inc.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Pharmaceutical Anti-Counterfeiting Strategies
Prescription Drug Counterfeiting
Pharmaceutical Counterfeiting in the EU: Where Are We Now?
The Global Report on Counterfeiting: Anti-counterfeiting and the Apparel Industry
Strategic Analysis of the North American Automotive Parts Counterfeiting and Gray Market
Global losses in pounds sterling due to counterfeiting and forgery, counterfeit retail goods, pirated software, pirated compact disks and cassettes, and from unlicensed medicines for 2000
Apparel Counterfeiting in China - Management Briefing
Business and Legal Strategies in Trademark Anti-Counterfeiting Enforcement: ReedLogic Video Seminar with Raymond R. Castello of Fish & Richardson P.C.
Chinese White-box and Counterfeit Netbook PCs: Current Status and Future Industry Impact
Counterfeit Car Parts in the Global Auto Industry
Low-Cost RFID Smart Labels - International Markets & Opportunities in Europe & North America
Analysis on Anti-cold Medicines in Recent Three Years
|
|
|
|
